PharVision Advisers’s Atour Lifestyle Holdings ATAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,130
Closed -$202K 141
2025
Q4
$202K Sell
5,130
-5,593
-52% -$219K 0.1% 552
2025
Q3
$403K Buy
+10,723
New +$392K 0.23% 80

Other funds holding ATAT

PharVision Advisers's ATAT Position: Q1 2026 in Review

PharVision Advisers sold out of Atour Lifestyle Holdings (ATAT) in Q1 2026, closing a stake of 5,130 shares — an estimated $202K sold.

PharVision Advisers first reported a position in ATAT in Q3 2025 and held it in 2 quarters. The position peaked at $403K in Q3 2025. 185 funds tracked by Wall St. Rank hold ATAT as of Q1 2026.

  • PharVision Advisers reported no remaining Atour Lifestyle Holdings position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 5,130 Atour Lifestyle Holdings shares in Q1 2026, an estimated $202K.
  • PharVision Advisers first reported a position in Atour Lifestyle Holdings in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's Atour Lifestyle Holdings position peaked at $403K in Q3 2025.
  • 185 funds tracked by Wall St. Rank held Atour Lifestyle Holdings as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.